Dr. Juan Li is an accomplished young specialist in urologic malignancies and melanoma in China. She served as a senior visiting scholar at the Moffitt Cancer Center in the United States, gaining robust international academic exposure and clinical research experience. Her work focuses on the comprehensive management of urologic cancers—including renal cell carcinoma, upper tract urothelial carcinoma, bladder cancer, prostate cancer, and other rare urologic tumors—as well as melanoma and sarcoma. She has extensive expertise in systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and cellular therapies.
As a Sub-Investigator, Dr. Li has participated in numerous domestic and international multi-center phase I–III clinical trials involving novel drugs and cellular therapies. As a key contributor, she has been involved in national key scientific research programs, National Natural Science Foundation projects, and multiple provincial-level research grants. She has published several SCI papers as first author in journals such as Lancet Oncology and The Innovation. Her research has been featured at major academic meetings including ASCO, ASCO-GU, ESMO, and CSCO, demonstrating her strong academic impact in clinical oncology research.
